We have a special interest in developing biopharmaceutical processes using a system approach. The production of virus-like particles (VLP), a vaccine platform, was selected as an initial project. For this purpose, we use a bench bioreactor and insect cell/baculovirus expression system. We have already produced VLP of rabies, Zika, and SARS-CoV-2 viruses since the beginning[…]

In order to perform our researches in a low investment framework, we are so grateful to our partners. Our current collaborators are: Instituto Butantan/ Laboratório de Imunologia Viral (website) Escola Politécnica-Universidade de São Paulo (USP)/ Departamento de Engenharia Química-Grupo de Engenharia de Bioprocessos (website) Escola Politécnica-Universidade de São Paulo (USP)/ Laboratório de Células Animais Universidade[…]